Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Transplant success has improved with better immunosuppressive drugs and donor matching.

No single treatment is consistently effective for alopecia areata, and more research is needed.

DHT may increase the risk of heart disease and death in elderly men.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

The best way to extract saponins from Eclipta prostrasta is using 70% ethanol, at 70°C for 3 hours with a 14:1 liquid to solid ratio.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Thymosin β4 helps improve skin healing and reduce scarring.

New compounds were found to help increase hair growth and decrease hair loss.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Immune cells affect hair growth and could lead to new hair loss treatments.

Using certain small proteins with a growth factor and specific materials can increase the creation of neurons from stem cells.

Protein hydrolysates applied to roots or leaves differently improved lettuce yield and quality, with the best results seen in specific combined treatments for each type.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.